# S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

> **NCT00045617** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 9 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** monoclonal antibody 11D10 anti-idiotype vaccine
- **BIOLOGICAL:** monoclonal antibody GD2 anti-idiotype vaccine
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00045617
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Closed due to lack of drug availability.
- **Last updated:** 2012-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045617, "S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00045617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*